BMC Endocrine Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.7 | Q2 | 59.0% | 1.024 | Q1 | 84.5% |
| 2024 | 3.3 | Q2 | 59.1% | 0.925 | Q1 | 82.1% |
| 2023 | 2.8 | Q3 | 47.7% | 0.789 | Q2 | 79.3% |
| 2022 | 2.7 | Q4 | 34.9% | 0.733 | Q2 | 78.1% |
| 2021 | 3.3 | Q3 | 47.5% | 0.728 | Q2 | 78.6% |
| 2020 | — | — | 0.744 | Q2 | 77.9% | |
| 2019 | — | — | 0.853 | Q2 | 81.9% | |
| 2018 | — | — | 0.829 | Q2 | 79.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1472-6823
country
GBcoverage
2001-2026